Zepp Health (ZEPP) Competitors

RADCOM (NASDAQ:RDCM) and Zepp Health (NYSE:ZEPP) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, community ranking, valuation, analyst recommendations, media sentiment, risk, earnings and profitability.

Does the media favor RDCM or ZEPP?

In the previous week, Zepp Health had 2 more articles in the media than RADCOM. MarketBeat recorded 5 mentions for Zepp Health and 3 mentions for RADCOM. RADCOM's average media sentiment score of 1.81 beat Zepp Health's score of -0.13 indicating that RADCOM is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RADCOM	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Zepp Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders & institutionals have more ownership in RDCM or ZEPP?

48.3% of RADCOM shares are held by institutional investors. Comparatively, 52.6% of Zepp Health shares are held by institutional investors. 69.0% of RADCOM shares are held by company insiders. Comparatively, 36.0% of Zepp Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Which has stronger valuation & earnings, RDCM or ZEPP?

RADCOM has higher earnings, but lower revenue than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than RADCOM, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RADCOM	$61.01M	3.05	$6.97M	$0.44	27.00
Zepp Health	$205.23M	0.23	-$29.88M	-$2.50	-1.23

Is RDCM or ZEPP more profitable?

RADCOM has a net margin of 11.42% compared to Zepp Health's net margin of -19.24%. RADCOM's return on equity of 8.18% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RADCOM	11.42%	8.18%	6.11%
Zepp Health	-19.24%	-12.03%	-6.69%

Which has more risk and volatility, RDCM or ZEPP?

RADCOM has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500. Comparatively, Zepp Health has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500.

Do analysts prefer RDCM or ZEPP?

RADCOM presently has a consensus target price of $16.00, suggesting a potential upside of 34.68%. Zepp Health has a consensus target price of $14.65, suggesting a potential upside of 377.20%. Given Zepp Health's higher possible upside, analysts plainly believe Zepp Health is more favorable than RADCOM.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RADCOM	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Zepp Health	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community prefer RDCM or ZEPP?

RADCOM received 341 more outperform votes than Zepp Health when rated by MarketBeat users. Likewise, 70.26% of users gave RADCOM an outperform vote while only 57.14% of users gave Zepp Health an outperform vote.

Company	Underperform	Outperform
RADCOM	Outperform Votes 345 70.26%	Underperform Votes 146 29.74%
Zepp Health	Outperform Votes 4 57.14%	Underperform Votes 3 42.86%

Summary

RADCOM beats Zepp Health on 12 of the 16 factors compared between the two stocks.